Cerebrovascular diseases and depression: Epidemiology, mechanisms and treatment

Panminerva Medica

Volumn 54, Issue 3, 2012, Pages 161-170

  Gothe F ^a,b   Enache ', D ^a   Wahlund, L O ^a,b   Winblad, B ^a,b   Crisby, M ^a   Lokk J ^a,b   Aarsland, D ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cerebrovascular disorders; Depression; Inflammation; Stroke

Indexed keywords

ANTIDEPRESSANT AGENT;

AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BIOLOGICAL MODEL; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); DEPRESSION; FEMALE; HUMAN; INFLAMMATION; MALE; MULTIINFARCT DEMENTIA; PATHOLOGY; PROGNOSIS; PSYCHOLOGICAL ASPECT; RISK;

AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; CEREBROVASCULAR DISORDERS; CLINICAL TRIALS AS TOPIC; DEMENTIA, VASCULAR; DEPRESSIVE DISORDER; FEMALE; HUMANS; INFLAMMATION; MALE; MODELS, BIOLOGICAL; PROGNOSIS; RISK; STROKE;

EID: 84867178666     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (100)

1. Association AP. DSM-IV. 4th edition. American Psychiatric Asso-ciation; 1994.
2. Sneed JR, Culang-Reinlieb ME. The vascular depression hypoth-esis: An update. Am J Geriatr Psychiatry 2011;19:99-103.
3. Meeks TW, Vahia IV, Lavretsky H, Kulkarni G, Jeste DV. A tune in "a minor" can "b major": A review of epidemiology, illness course, and public health implications of subthreshold depression in older adults. J Affect Disord 2011;129:126-42.
4. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. 'Vascular depression' hypothesis. Arch Gen Psy-chiatry 1997;54:915-22. (Pubitemid 128719702)
5. Kouwenhoven SE, Kirkevold M, Engedal K, Kim HS. Depression in acute stroke: prevalence, dominant symptoms and associated fac-tors. A systematic literature review. Disabil Rehabil 2011;33:539-56.
6. Choi-Kwon S, Han K, Choi S, Suh M, Kim YJ, Song H et al. Post-stroke depression and emotional incontinence: Factors related to acute and subacute stages. Neurology 2012;78:1130-7.
7. Ayerbe L, Ayis S, Rudd AG, Heuschmann PU, Wolfe CD. Natu-ral history, predictors, and associations of depression 5 years after stroke: The South London stroke register. Stroke 2011;42:1907-11.
8. Luijendijk HJ, Stricker BH, Wieberdink RG, Koudstaal PJ, Hof-man A, Breteler MM et al. Transient ischemic attack and incident depression. Stroke 2011;42:1857-61.
9. Kotila M, Numminen H, Waltimo O, Kaste M. Post-stroke depres-sion and functional recovery in a population-based stroke register. The Finnstroke study. Eur J Neurol 1999;6:309-12. (Pubitemid 29250990)
10. Morris PL, Robinson RG, Andrzejewski P, Samuels J, Price TR. Association of depression with 10-year poststroke mortality. Am J Psychiatry 1993;150:124-9. (Pubitemid 23059176)
11. Ried LD, Jia H, Feng H, Cameon R, Wang X, Tueth M et al. Selec-tive serotonin reuptake inhibitor treatment and depression are asso-ciated with poststroke mortality. Ann Pharmacother 2011;45:888-97.
12. House A, Knapp P, Bamford J, Vail A. Mortality at 12 and 24 months after stroke be associated with depressive symptoms at 1 month. Stroke 2001;32:696-701.
13. Andersen G, Vestergaard K, Ingemann-Nielsen M, Lauritzen L. Risk factors for post-stroke depression. Acta Psychiatr Scand 1995;92:193-8.
14. Leentjens AF, Aben I, Lodder J, Verhey FR. General and disease-specific risk factors for depression after ischemic stroke: a two-step Cox regression analysis. Int Psychogeriatr 2006;18:739-48. (Pubitemid 44623005)
15. Paradiso S, Robinson RG. Gender differences in poststroke depres-sion. J Neuropsychiatry Clin Neurosci 1998 Winter; 10:41-7.
16. Kaji Y, Hirata K, Ebata A. Characteristics of post-stroke depression in Japanese patients. Neuropsychobiology 2006;53:148-52. (Pubitemid 43854174)
17. Robinson-Smith G, Johnston MV, Allen J. Self-care self-efficacy, quality of life, and depression after stroke. Arch Phys Med Rehabil 2000 Apr;81:460-4. (Pubitemid 30192039)
18. Berg A, Palomaki H, Lehtihalmes M, Lonnqvist J, Kaste M. Post-stroke depression: An 18-month follow-up. Stroke 2003;34:138-43.
19. Nys GM, van Zandvoort MJ, van der Worp HB, de Haan EH, de Kort PL, Kappelle LJ. Early depressive symptoms after stroke: Neuropsychological correlates and lesion characteristics. J Neurol Sci 2005 15;228:27-33.
20. Aben I, Lodder J, Honig A, Lousberg R, Boreas A, Verhey F. Focal or generalized vascular brain damage and vulnerability to depres-sion after stroke: A 1-year prospective follow-up study. Int Psycho-geriatr 2006;18:19-35.
21. Greenop KR, Almeida OP, Hankey GJ, van Bockxmeer F, Lau-tenschlager NT. Premorbid personality traits are associated with post-stroke behavioral and psychological symptoms: A three-month follow-up study in Perth, Western Australia. Int Psychogeriatr 2009;21:1063-71.
22. Kellermann M, Fekete I, Gesztelyi R, Csiba L, Kollar J, Sikula J et al. Screening for depressive symptoms in the acute phase of stroke. Gen Hosp Psychiatry 1999;21:116-21. (Pubitemid 29200433)
23. Heller AS, Johnstone T, Shackman AJ, Light SN, Peterson MJ, Kolden GG et al. Reduced capacity to sustain positive emotion in major depression reflects diminished maintenance of fronto-striatal brain activation. Proc Natl Acad Sci U S A 2009 29;106:22445-50.
24. Robinson RG, Price TR. Post-stroke depressive disorders: a fol-low-up study of 103 patients. Stroke 1982;13:635-41. (Pubitemid 12011074)
25. Gonzalez Torrecillas JI, Mendlewicz J, Lobo A Med Clin (Barc) 1997;109:241-4.
26. Iacoboni M, Padovani A, Di Piero V, Lenzi GL. Post-stroke depres-sion: Relationships with morphological damage and cognition over time. Ital J Neurol Sci 1995;16:209-16.
27. Ramasubbu R, Tobias R, Buchan AM, Bech-Hansen NT. Serotonin transporter gene promoter region polymorphism associated with poststroke major depression. J Neuropsychiatry Clin Neurosci 2006 Winter;18:96-9. (Pubitemid 43277262)
28. Tenev VT, Robinson RG, Jorge RE. Is family history of depression a risk factor for poststroke depression? Meta-analysis. Am J Geri-atr Psychiatry 2009;17:276-80.
29. Laucht M, Treutlein J, Blomeyer D, Buchmann AF, Schmid B, Becker K et al. Interaction between the 5-HTTLPR serotonin transporter polymorphism and environmental adversity for mood and anxiety psychopathology: Evidence from a high-risk com-munity sample of young adults. Int J Neuropsychopharmacol 2009;12:737-47.
30. Fang J, Yan W, Jiang GX, Li W, Cheng Q. Serotonin transporter gene polymorphism in Chinese patients with poststroke depres-sion: A case-control study. Stroke 2011;42:1461-3.
31. Ramasubbu R, Tobias R, Bech-Hansen NT. Extended evaluation of serotonin transporter gene functional polymorphisms in subjects with post-stroke depression. Can J Psychiatry 2008;53:197-201. (Pubitemid 351469379)
32. McCaffery JM, Duan QL, Frasure-Smith N, Barhdadi A, Lesper-ance F, Theroux P et al. Genetic predictors of depressive symp-toms in cardiac patients. Am J Med Genet B Neuropsychiatr Genet 2009;150B:381-8.
33. McCaffery JM, Frasure-Smith N, Dube MP, Theroux P, Rouleau GA, Duan Q et al. Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psycho-som Med 2006;68:187-200. (Pubitemid 43740120)
34. Zhou Z, Lu T, Xu G, Yue X, Zhu W, Ma M et al.Reased serum brain-derived neurotrophic factor (BDNF) is associated with post-stroke depression but not with BDNF gene Val66Met polymorphism. Clin Chem Lab Med 2011;49:185-9.
35. Bowirrat A, Oscar-Berman M, Logroscino G. Association of de-pression with Alzheimer's disease and vascular dementia in an eld-erly Arab population of Wadi-Ara, Israel. Int J Geriatr Psychiatry 2006;21:246-51.
36. Enache D, Winblad B, Aarsland D. Depression in dementia: Epi-demiology, mechanisms, and treatment. Curr Opi Psychiatry 2011;24:461-72.
37. Park JH, Lee SB, Lee TJ, Lee DY, Jhoo JH, Youn JC et al. Depres-sion in vascular dementia is quantitatively and qualitatively differ-ent from depression in Alzheimer's disease. Dement Geriatr Cogn Disord 2007;23:67-73. (Pubitemid 46105696)
38. Castilla-Puentes RC, Habeych ME. Subtypes of depression among patients with Alzheimer's disease and other dementias. Alzheimers Dement 2010;6:63-9.
39. Wetzels RB, Zuidema SU, de Jonghe JF, Verhey FR, Koopmans RT. Course of neuropsychiatric symptoms in residents with demen-tia in nursing homes over 2-year period. Am J Geriatr Psychiatry 2010;18:1054-65.
40. Mayberg HS. Frontal lobe dysfunction in secondary depression. J Neuropsychiatry Clin Neurosci 1994;6:428-42. (Pubitemid 24344863)
41. Culang-Reinlieb ME, Johnert LC, Brickman AM, Steffens DC, Garçon E, Sneed JR. MRI-defined vascular depression: A review of the construct. Int J Geriatr Psychiatry 2010;29.
42. Aizenstein HJ, Butters M A, Figurski JL, Stenger VA, Reynolds CF, 3rd, Carter CS. Prefrontal and striatal activation during sequence learning in geriatric depression. Biol Psychiatry 2005 15;58:290-6.
43. Aizenstein HJ, Butters M A, Wu M, Mazurkewicz LM, Stenger VA, Gianaros PJ et al. Altered functioning of the executive control cir-cuit in late-life depression: Episodic and persistent phenomena. Am J Geriatr Psychiatry 2009; 17:30-42.
44. Aizenstein HJ, Andreescu C, Edelman KL, Cochran JL, Price J, Butters M A et al. fMRI correlates of white matter hyperintensities in late-life depression. Am J Psychiatry 2011;168:1075-82.
45. Fotuhi M, Do D, Jack C. Modifiable factors that alter the size of the hippocampus with ageing. Nat Rev Neurol 2012;8:189-202.
46. Kim JM, Stewart R, Bae KY, Kim SW, Kang HJ, Shin IS et al. Serotonergic and BDNF genes and risk of depression after stroke. J Affect Disord 2012;136:833-40.
47. Elliott MS, Ballard CG, Kalaria RN, Perry R, Hortobagyi T, Fran-cis PT. Increased binding to 5-HT1A and 5-HT2A receptors is as-sociated with large vessel infarction and relative preservation of cognition. Brain 2009;132(Pt 7):1858-65.
48. Raison CL, Miller AH. Is depression an inflammatory disorder? Curr Psychiatry Rep 2011;13:467-75.
49. Wang X, Yue TL, Barone FC, White RF, Gagnon RC, Feuerstein GZ. Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol 1994;23:103-14.
50. Saito K, Suyama K, Nishida K, Sci Y, Basile AS. Early increases in TNF-alpha, IL-6 and IL-I beta levels following transient cerebral ischemia in gerbil brain. Neurosci Lett 1996;206:149-52.
51. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN et al. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 1997;28:1233-44. (Pubitemid 27248902)
52. Hakim AM. Depression, strokes and dementia: New biological in-sights into an unfortunate pathway. Cardiovasc Psychiatry Neurol 2011;2011:649629.
53. Paranthaman R, Greenstein AS, Burns AS, Craickshank JK, Heagerty AM, Jackson A et al. Vascular function in older adults with depressive disorder. Biol Psychiatry 2010 15;68:133-9.
54. Greenstein AS, Paranthaman R, Burns A, Jackson A, Malik RA, Baldwin RC et al. Cerebrovascular damage in late-life depression is associated with structural and functional abnormalities of subcu-taneous small arteries. Hypertension 2010;56:734-40.
55. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Com-mon carotid intima-media thickness and risk of stroke and myocar-dial infarction: the Rotterdam Study. Circulation 1997;96:1432-7. (Pubitemid 27375333)
56. Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Ni-eto FJ et al. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2000;151:478-87. (Pubitemid 30471022)
57. Smith PJ, Blumenthal JA, Babyak MA, Doraiswamy PM, Hinder-liter A, Hoffman BM et al. Intima-media thickness and age of first depressive episode. Biol Psychol 2009;80:361-4.
58. Tiemeier H, van Dijck W, Hofman A, Witteman JC, Stijnen T, Breteler MM. Relationship between atherosclerosis and late-life depression: the Rotterdam Study. Arch Gen Psychiatry 2004;61:369-76. (Pubitemid 38451546)
59. Newson RS, Hek K, Luijendijk HJ, Hofman A, Witteman JC, Tie-meier H. Atherosclerosis and incident depression in late life. Arch Gen Psychiatry 2010;67:1144-51.
60. Pizzi C, Manzoli L, Mancini S, Bedetti G, Fontana F, Costa GM. Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors. Atherosclerosis 2010;212:292-8.
61. Badimon L,tinez-Gonzalez J, Royo T, Lassila R, Badimon JJ. A sudden increase in plasma epinephrine levels transiently enhances platelet deposition on severely damaged arterial wall-studies in a porcine model. Thromb Haemost 1999;82:1736-42.
62. Dzau VJ, Sacks FM. Regulation of lipoprotein metabolism by adren-ergic mechanisms. J Cardiovasc Pharmacol 1987;10(Suppl 9):S2-6. (Pubitemid 17168074)
63. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004;25:363-70.
64. Meng L, Chen D, Yang Y, Zheng Y, Hui R. Depression increases the risk of hypertension incidence: A meta-analysis of prospective cohort studies. J Hypertens 2012;30:842-51.
65. Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB. Depression and risk of stroke morbidity and mortality: A meta-analysis and system-atic review. Jama 2011 21;306:1241 -9.
66. Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 1995;152:1372-6.
67. Miller AH PB, Pariante CM. In: V.A. SBJS, editor. Comprehen-sive Textbook of Psychiatry. Philadelphia: Lippincott Williams and Wilkins; 2000.
68. Silverman MN, Pearce BD, Biron CA, Miller AH. Immune modu-lation of the hypothalamic-pituitary-adrenal (HPA) axis during vi-ral infection. Viral Immunol 2005;18:41-78. (Pubitemid 40586446)
69. Tsopelas C, Stewart R, Savva GM, Brayne C, Ince P, Thomas A et al. Neuropathological correlates of late-life depression in older people. Br J Psychiatry 2011;198:109-14.
70. Colloby SJ, Firbank MJ, Thomas AJ, Vasudev A, Parry SW, O'Brien JT. White matter changes in late-life depression: A diffu-sion tensor imaging study. J Affect Disord 2011;135:216-20.
71. Kenny ER, O'Brien JT, Cousins DA, Richardson J, Thomas AJ, Firbank MJ et al. Functional connectivity in late-life depression using resting-state functional magnetic resonance imaging. Am J Geriatr Psychiatry 2010;18:643-51.
72. Krishnan MS, O'Brien JT, Firbank MJ, Pantoni L, Carlucci G, Erkinjuntti T et al. Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study. Int J Geriatr Psychiatry 2006;21:983-9. (Pubitemid 44596394)
73. O'Brien JT, Firbank MJ, Krishnan MS, van Straaten EC, van der Flier WM, Petrovic K et al. White matter hyperintensities rather than lacunar infarcts are associated with depressive symp-toms in older people: the LADIS study. Am J Geriatr Psychiatry 2006;14:834-41. (Pubitemid 44556477)
74. Teodorczuk A, O'Brien JT, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T et al. White matter changes and late-life depressive symptoms: longitudinal study. BrJ Psychiatry 2007;191:212-7. (Pubitemid 47435050)
75. Teodorczuk A, Firbank MJ, Pantoni L, Poggesi A, Erkinjuntti T, Wallin A et al. Relationship between baseline white-matter chang-es and development of late-life depressive symptoms: 3-year re-sults from the LADIS study. Psychol Med 2010;40:603-10.
76. Soennesyn H OK, Greve OJ, Fritze F, Auestad B; Nore SP, Beyer MK, Aarsland D. White matter hyperintensities and the course of depressive symptoms in elderly people with mild dementia. De-ment Geriatr Cogn Disord 2012;2:97-111.
77. Colloby SJ, Vasudev A, O'Brien JT, Firbank MJ, Parry SW, Tho-mas AJ. Relationship of orthostatic blood pressure to white matter hyperintensities and subcortical volumes in late-life depression. Br J Psychiatry 2011;199:404-10.
78. Sexton CE, Mackay CE, Ebmeier KP. A systematic review of diffu-sion tensor imaging studies in affective disorders. Biol Psychiatry 2009 1;66:814-23.
79. Lokk J, Delbari A. Management of depression in elderly stroke pa-tients. Neuropsychiatr Dis Treat 2010;6:539-49.
80. Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): A randomised placebo-controlled trial. Lancet Neurol 2011;10:123-30.
81. Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008:CD003437.
82. Mitchell PH, Veith RC, Becker KJ, Buzaitis A, Cain KC, Fruin M et al. Brief psychosocial-behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant: living well with stroke: randomized, con-trolled trial. Stroke 2009;40:3073-8.
83. Yi ZM, Liu F, Zhai SD. Fluoxetine for the prophylaxis of post-stroke depression in patients with stroke: a meta-analysis. Int J Clin Pract 2010;64:1310-7.
84. Robinson RG, Jorge RE, Moser DJ, Ación L, Solodkin A, Small SL et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: A randomized controlled trial. Jama 2008 28;299:2391-400.
85. Tsai CS, Wu CL, Chou SY, Tsang HY, Hung TH, Su JA. Prevention of poststroke depression with milnacipran in patients with acute ischemic stroke: A double-blind randomized placebo-controlled trial. Int Clin Psychopharmacol 2011;26:263-7.
86. Almeida OP,Sh K, Alfonso H, Flicker L, Davis TM, Hankey GJ. B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial. Ann Neurol 2010;68:503-10.
87. Mikami K, Jorge RE, Moser DJ, Arndt S,g M, Solodkin A et al. Increased frequency of first-episode poststroke depression after discontinuation of escitalopram. Stroke 2011;42:3281-3.
88. Jorge RE, Acion L, Moser D, Adams HP, Jr., Robinson RG. Esci-talopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 2010;67:187-96.
89. Mikami K, Jorge RE, Adams HP, Jr., Davis PH, Leira EC,g M et al. Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry 2011;19:1007-15.
90. Choi-Kwon S, Han SW, Kwon SU, Kang DW, Choi JM, Kim JS. Fluoxetine treatment in poststroke depression, emotional incon-tinence, and anger proneness: a double-blind, placebo-controlled study. Stroke 2006;37:156-61. (Pubitemid 43732065)
91. Kohen R, Cain KC, Buzaitis A, Johnson V, Becker KJ, Teri L et al. Response to psychosocial treatment in poststroke depression is associated with serotonin transporter polymorphisms. Stroke 2011;42:2068-70.
92. Branoni AR, Bensenor IM, Alves TC. Therapeutic interventions for vascular depression: A systematic review. Rev Bras Psiquiatr 2011;33:400-9.
93. Taragano FE, Bagnatti P, Allegri RF. A double-blind, randomized clinical trial to assess thementation with nimodipine of antidepres-sant therapy in the treatment of "vascular depression". Int Psycho-geriatr 2005; 17:487-98. (Pubitemid 41391692)
94. Paranthaman R, Greenstein A, Burns AS, Heagerty AM, Malik RA, Baldwin RC. Relationship of endothelial function and atheroscle-rosis to treatment response in late-life depression. Int J Geriatr Psy-chiatry 2012 9.
95. Sneed JR, Culang-Reinlieb ME, Brickman AM, Gunning-Dixon FM, Johnert L, Garcon E et al. MRI signal hyperintensities and failure to remit following antidepressant treatment. J Affect Disord 2011;135(1-3):315-20.
96. Payne ME, Hybels CF, Bales CW, Steffens DC. Vascular nutri-tional correlates of late-life depression. Am J Geriatr Psychiatry 2006;14:787-95. (Pubitemid 44380071)
97. Young-Xu Y, Chan KA, Liao JK, Ravid S, Blatt CM. Long-term statin use and psychological well-being. J Am Coll Cardiol 2003 20;42:690-7.
98. Stafford L, Berk M. The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: Proof of concept for the inflammatory and oxidative hypotheses of depres-sion? J Clin Psychiatry 2011;72:1229-35.
99. Steffens DC, McQuoid DR, Krishnan KR. Cholesterol-lowering medication and relapse of depression. Psychopharmacol Bull 2003;37:92-8.
100. Asplund K, Eriksson M. Inflammation, poststroke depression and statins. Int J Stroke 2011;6:567-8.